Home › Funds › BRISTOL JOHN W & CO INC /NY/ › NVS

BRISTOL JOHN W & CO INC /NY/ position in NVS

NOVARTIS AG · Health Care

BRISTOL JOHN W & CO INC /NY/ reported holding 545,446 shares of NVS (NOVARTIS AG) in its Q3 2026 13F filing — a position valued at US$77.8M, representing 1.18% of its reported portfolio and ranking #37 among its reported holdings. BRISTOL JOHN W & CO INC /NY/ has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)545.45K sh
Reported value held$77.76M
Portfolio Weight1.18%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How BRISTOL JOHN W & CO INC /NY/'s NVS position evolved

BRISTOL JOHN W & CO INC /NY/ first disclosed a stake in NVS in Q3 2023 at 675,409 shares (US$68.8M). The position peaked in Q2 2026 at 557,777 shares, worth US$87.4M. Across 13 filings, BRISTOL JOHN W & CO INC /NY/ increased the stake 0 time(s), trimmed it 10 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 545,446 shares valued at US$77.8M — a reduction of -12,331 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 675.41K $68.80M New
Q4 2023 642.75K $64.90M Reduce
Q1 2024 638.56K $61.77M Reduce
Q2 2024 624.92K $66.53M Reduce
Q3 2024 623.71K $71.74M Hold
Q4 2024 609.68K $59.33M Reduce
Q1 2025 593.73K $66.19M Reduce
Q2 2025 592.28K $71.67M Hold
Q3 2025 581.72K $74.60M Reduce
Q4 2025 569.72K $78.55M Reduce
Q1 2026 561.84K $85.82M Reduce
Q2 2026 557.78K $87.41M Reduce
Q3 2026 545.45K $77.76M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVS and 13F data

NVS (NOVARTIS AG) is a Health Care company. 20 other funds we track also report a position in NVS — the largest reported positions include Fisher Asset Management, LLC (US$2.39B), PRIMECAP MANAGEMENT CO/CA/ (US$938.9M), LOOMIS SAYLES & CO L P (US$689.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVS

All NVS fund holders →

FAQ

How long has BRISTOL JOHN W & CO INC /NY/ held NVS?

BRISTOL JOHN W & CO INC /NY/ has disclosed NVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BRISTOL JOHN W & CO INC /NY/'s current position in NVS?

As of Q3 2026, BRISTOL JOHN W & CO INC /NY/ holds 545.45K shares of NVS (NOVARTIS AG), valued at $77.76M, representing 1.18% of its reported portfolio and ranking #37.

Has BRISTOL JOHN W & CO INC /NY/ been buying or selling NVS?

In the latest 13F filing (Q3 2026), BRISTOL JOHN W & CO INC /NY/ reduced its position in NVS. The position peaked in Q2 2026 at 557.78K shares.

Which other funds hold NVS?

Other major institutional holders of NVS include Fisher Asset Management, LLC, PRIMECAP MANAGEMENT CO/CA/, LOOMIS SAYLES & CO L P, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.